Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - scPharmaceuticals Inc. | ck0001604950-ex322_6.htm |
| EX-32.1 - EX-32.1 - scPharmaceuticals Inc. | ck0001604950-ex321_7.htm |
| EX-31.2 - EX-31.2 - scPharmaceuticals Inc. | ck0001604950-ex312_8.htm |
| EX-31.1 - EX-31.1 - scPharmaceuticals Inc. | ck0001604950-ex311_9.htm |
| 10-K - 10-K - scPharmaceuticals Inc. | ck0001604950-10k_20171231.htm |
|
|
|
|
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement (No. 333-221677) on Form S-8 of scPharmaceuticals, Inc. of our report dated March 20, 2018, relating to the financial statements of scPharmaceuticals, Inc., appearing in this Annual Report on Form 10-K of scPharmaceuticals, Inc. for the year ended December 31, 2017.
/s/ RSM US LLP
Boston, Massachusetts
March 20, 2018
|
|
|
|